The Detrimental Role Played by Lipocalin-2 in Alcoholic Fatty Liver in Mice

American Journal of Pathology - United States
doi 10.1016/j.ajpath.2016.05.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

High Susceptibility to Non-Alcoholic Fatty Liver Disease in Two-Pore Channel 2-Deficient Mice

Biophysical Journal
Biophysics
2015English

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System

Frontiers in Pharmacology
Pharmacology
2020English

Lipocalin‐2 Protects Against Diet‐Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes

Hepatology Communications
Hepatology
2019English

Liraglutide Improves Non-Alcoholic Fatty Liver Disease in Diabetic Mice by Modulating Inflammatory Signaling Pathways

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Pentoxifylline Ameliorates Non-Alcoholic Fatty Liver Disease in Hyperglycaemic and Dyslipidaemic Mice by Upregulating Fatty Acid Β-Oxidation

Scientific Reports
Multidisciplinary
2016English

Lactobacillus Rhamnosus GG Protects Against Non-Alcoholic Fatty Liver Disease in Mice

PLoS ONE
Multidisciplinary
2014English

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease

Children
2017English

The Fat-Derived Hormone Adiponectin Alleviates Alcoholic and Nonalcoholic Fatty Liver Diseases in Mice

Journal of Clinical Investigation
Medicine
2003English

Nuclear Receptor-Mediated Alleviation of Alcoholic Fatty Liver by Polyphenols Contained in Alcoholic Beverages

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy